.png)
Large Diagnostics
Clinical Marketing, Government Affairs, Medical Affairs Teams
Launched
Gastroenterology
Subscribe to our newsletter to receive the latest case studies.
Large Diagnostics
Clinical Marketing, Government Affairs, Medical Affairs Teams
Launched
Gastroenterology
A large diagnostics company had launched a new set of GI diagnostic panels and was beginning to face increasingly restrictive payer coverage.
While the panels offered clinical breadth, decision-makers required clearer evidence demonstrating value across clinical, economic, and patient-centered outcomes.
The client engaged Alkemi to identify where evidence was most needed and to prioritize a focused plan to strengthen the value narrative for clinical and economic decision-makers.
1. Reviewed existing evidence, clinical guidelines, and payer policies to assess opportunities to demonstrate differentiated value.
2. Conducted interviews with internal and external stakeholders to understand decision drivers, evidence expectations, and perceived gaps.
3. Led a cross-functional workshop to prioritize evidence gaps and align on data generation approaches.
4. Developed a clear, execution-ready evidence generation plan to guide near- and mid-term activities.
Invest in the evidence that most directly influences decisions.
"Thanks for keeping us organized!" - Senior Marketing Manager, Market Shaping & Development
Teams aligned on shared evidence priorities and investment focus.
The client clarified how value should be articulated to different decision-makers.
A prioritized evidence plan positioned the organization to address payer concerns more effectively and support broader use.